
Highly precise risk prediction model for new‐onset hypertension using artificial intelligence techniques
Author(s) -
Kanegae Hiroshi,
Suzuki Kenji,
Fukatani Kyohei,
Ito Tetsuya,
Harada Nakahiro,
Kario Kazuomi
Publication year - 2020
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.13759
Subject(s) - medicine , logistic regression , receiver operating characteristic , machine learning , artificial intelligence , blood pressure , population , environmental health , computer science
Hypertension is a significant public health issue. The ability to predict the risk of developing hypertension could contribute to disease prevention strategies. This study used machine learning techniques to develop and validate a new risk prediction model for new‐onset hypertension. In Japan, Industrial Safety and Health Law requires employers to provide annual health checkups to their employees. We used 2005‐2016 health checkup data from 18 258 individuals, at the time of hypertension diagnosis [Year (0)] and in the two previous annual visits [Year (−1) and Year (−2)]. Data were entered into models based on machine learning methods (XGBoost and ensemble) or traditional statistical methods (logistic regression). Data were randomly split into a derivation set (75%, n = 13 694) used for model construction and development, and a validation set (25%, n = 4564) used to test performance of the derived models. The best predictor in the XGBoost model was systolic blood pressure during cardio‐ankle vascular index measurement at Year (−1). Area under the receiver operator characteristic curve values in the validation cohort were 0.877, 0.881, and 0.859 for the XGBoost, ensemble, and logistic regression models, respectively. We have developed a highly precise prediction model for future hypertension using machine learning methods in a general normotensive population. This could be used to identify at‐risk individuals and facilitate earlier non‐pharmacological intervention to prevent the future development of hypertension.